This company has been marked as potentially delisted and may not be actively trading. NASDAQ:FLKS Flex Pharma (FLKS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Flex Pharma Stock (NASDAQ:FLKS) 30 days 90 days 365 days Advanced Chart Get Flex Pharma alerts:Sign Up Key Stats Today's Range$0.76▼$0.8350-Day Range$0.57▼$14.5152-Week Range$0.26▼$1.49Volume24,249 shsAverage Volume2.03 million shsMarket Capitalization$14.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFlex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise-associated muscle cramps in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which completed an exploratory Phase II clinical trial in Australia for the treatment of patients with multiple sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT products online through its direct-to-consumer Website and through third-party Websites, including a retailer that offers international shipping. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.Read More… Receive FLKS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Flex Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address FLKS Stock News HeadlinesFLEX LNG: A Bond-Like 11.9% Yield To Lock Before Rate CutsSeptember 9, 2024 | seekingalpha.comFLEX LNG Ltd. (FLNG) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.May 30, 2025 | Paradigm Press (Ad)Construction Partners, Inc. (ROAD) Q3 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comWayfair Inc. (W) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | seekingalpha.comQ2 2024 AGCO Corp Earnings CallJuly 31, 2024 | finance.yahoo.comFlex Ltd. (FLEX) Q1 2025 Earnings Call TranscriptJuly 24, 2024 | seekingalpha.comFlex Ltd.: Undervalued With Solid FundamentalsApril 4, 2024 | seekingalpha.comSee More Headlines FLKS Stock Analysis - Frequently Asked Questions How were Flex Pharma's earnings last quarter? Flex Pharma Inc (NASDAQ:FLKS) released its quarterly earnings data on Wednesday, May, 1st. The biotechnology company reported ($0.12) EPS for the quarter. The biotechnology company earned $0.11 million during the quarter. Flex Pharma had a negative net margin of 1,208.42% and a negative trailing twelve-month return on equity of 98.04%. When did Flex Pharma IPO? Flex Pharma (FLKS) raised $60 million in an initial public offering on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers. What other stocks do shareholders of Flex Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Flex Pharma investors own include Micron Technology (MU), Ocular Therapeutix (OCUL), SCYNEXIS (SCYX), Idera Pharmaceuticals (IDRA), Celldex Therapeutics (CLDX), Gilead Sciences (GILD) and Histogenics (HSGX). Company Calendar Last Earnings5/01/2019Today5/29/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:FLKS CIK1615219 Webwww.flex-pharma.com Phone617-874-1821FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$21.92 million Net Margins-1,208.42% Pretax MarginN/A Return on Equity-98.04% Return on Assets-83.37% Debt Debt-to-Equity RatioN/A Current Ratio6.86 Quick Ratio6.74 Sales & Book Value Annual Sales$840,000.00 Price / Sales17.21 Cash FlowN/A Price / Cash FlowN/A Book Value$0.51 per share Price / Book1.57Miscellaneous Outstanding Shares18,070,000Free FloatN/AMarket Cap$14.46 million OptionableNot Optionable Beta1.65 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:FLKS) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersBuffett’s Next Move Could Shock Wall StreetIn just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.